Connect your AI

Shore Bancshares SHBI Proceeds from maturities of marketable securities

Proceeds from maturities of marketable securities at other companies

EyePoint, Inc. EYPT

$80.93M+76.9%

AbCellera Biologics Inc.ABCL

$143.8M-24.3%

KEE

Keel Infrastructure Corp. Common StockKEEL

$989K-85.7%

NextNavNN

$84M+143%

ZymeworksZYME

$70.18M+50.7%

Oruka Therapeutics, Inc.ORKA

$76.47M-12.3%

Other financials

Income statement

Revenue$59.8M+12.8%

Net income$17.1M+24.1%

EPS (diluted)$0.51+24.4%

Balance sheet

Cash & equivalents$340.8M-12.4%

Total debt$10.6M-12.9%

Total equity$602.7M+9.1%

Total assets$6.2B+0.5%

Cash flow

Operating cash flow$31.6M+59.6%

CapEx$1.1M+6.2%

Free cash flow$30.5M+62.5%

Valuation

Market cap$762.8M+56.3%

Enterprise value$432.58M+289%

P/E12.1×+2.3×

P/S3.3×+0.9×

Profitability

Net margin27.1%+3.2pp

FCF margin28.9%—

Returns & leverage

Return on equity10.9%+1.6pp

Debt / equity0×0.0×

Where this comes from

Reported directly by Shore Bancshares in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities.

The official record: Shore Bancshares’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shore Bancshares's proceeds from maturities of marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Shore Bancshares's proceeds from maturities of marketable securities?: Shore Bancshares (SHBI) reported proceeds from maturities of marketable securities of $0 in Q1 2026.